These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8521643

  • 1. [A case of Guillain-Barré syndrome associated with anti-GM2 antibody due to cytomegalovirus infection--special reference to the effect of ganciclovir].
    Niwa K, Kitagawa Y, Ohta T, Shinohara Y, Saito T.
    Rinsho Shinkeigaku; 1995 Jun; 35(6):652-6. PubMed ID: 8521643
    [Abstract] [Full Text] [Related]

  • 2. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
    Shimoya K, Ohnishi A, Hashimoto T, Yuki N.
    Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
    [Abstract] [Full Text] [Related]

  • 3. [A case of Guillain-Barré syndrome associated with cytomegalovirus infection].
    Kaneshige Y, Hirayama T, Matsumoto H, Chiba S, Kobayashi N.
    Rinsho Shinkeigaku; 1991 Jun; 31(6):680-3. PubMed ID: 1657481
    [Abstract] [Full Text] [Related]

  • 4. [Guillain-Barré syndrome and disturbance in multiple organs associated with cytomegalovirus infection].
    Harada T, Kohriyama T, Ishizaki F, Nakamori K, Nakagawa Y, Ohtani M, Kito S.
    No To Shinkei; 1990 Mar; 42(3):245-51. PubMed ID: 2164409
    [Abstract] [Full Text] [Related]

  • 5. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection.
    Irie S, Saito T, Nakamura K, Kanazawa N, Ogino M, Nukazawa T, Ito H, Tamai Y, Kowa H.
    J Neuroimmunol; 1996 Aug; 68(1-2):19-26. PubMed ID: 8784256
    [Abstract] [Full Text] [Related]

  • 6. [Steroid-pulse therapy in Guillain-Barré syndrome associated with cytomegalovirus infection: a case report].
    Tada M, Onodera O, Kawachi I, Hara K, Sato M, Yoshino H, Asano A, Soma Y, Tsuji S.
    No To Shinkei; 2003 Jul; 55(7):615-21. PubMed ID: 12910997
    [Abstract] [Full Text] [Related]

  • 7. Acute cytomegalovirus infection and IgM anti-GM2 antibody.
    Yuki N, Tagawa Y.
    J Neurol Sci; 1998 Jan 21; 154(1):14-7. PubMed ID: 9543317
    [Abstract] [Full Text] [Related]

  • 8. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome.
    Jacobs BC, van Doorn PA, Groeneveld JH, Tio-Gillen AP, van der Meché FG.
    J Neurol Neurosurg Psychiatry; 1997 Jun 21; 62(6):641-3. PubMed ID: 9219756
    [Abstract] [Full Text] [Related]

  • 9. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C, Vial C, Bancel J, Petiot P, Antoine JC, Gonnaud PM.
    Ann Biol Clin (Paris); 2002 Jun 21; 60(5):589-97. PubMed ID: 12368145
    [Abstract] [Full Text] [Related]

  • 10. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
    Ang CW, Jacobs BC, Brandenburg AH, Laman JD, van der Meché FG, Osterhaus AD, van Doorn PA.
    Neurology; 2000 Apr 11; 54(7):1453-8. PubMed ID: 10751257
    [Abstract] [Full Text] [Related]

  • 11. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
    Khalili-Shirazi A, Gregson N, Gray I, Rees J, Winer J, Hughes R.
    J Neurol Neurosurg Psychiatry; 1999 Mar 11; 66(3):376-9. PubMed ID: 10084538
    [Abstract] [Full Text] [Related]

  • 12. [A case of Guillain-Barré syndrome with bulbar palsy and a high titer of anti-GT1a antibody].
    Hashiguchi S, Ogasawara N, Yoshino H.
    Rinsho Shinkeigaku; 1997 Apr 11; 37(4):331-3. PubMed ID: 9248344
    [Abstract] [Full Text] [Related]

  • 13. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F, Alberú J, Soto-Ramírez LE, González-Aguirre H, Muñoz Trejo T, Mancilla E, Díliz H, Correa-Rotter R, Sierra-Madero J.
    Rev Invest Clin; 2002 Apr 11; 54(3):198-203. PubMed ID: 12183888
    [Abstract] [Full Text] [Related]

  • 14. [Prevalence and characteristics of Guillain-Barré syndromes associated with Campylobacter jejuni and cytomegalovirus in greater Paris].
    Sivadon V, Orlikowski D, Rozenberg F, Quincampoix JC, Caudie C, Durand MC, Fauchère JL, Sharshar T, Raphaël JC, Gaillard JL.
    Pathol Biol (Paris); 2005 Apr 11; 53(8-9):536-8. PubMed ID: 16084033
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 11; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 16. [Successful corticosteroid therapies in a case of acute motor, sensory, autonomic neuropathy after cytomegalovirus infection].
    Uchida Y, Koike H, Oguri T, Kato H, Yuasa H, Mitake S.
    Rinsho Shinkeigaku; 2015 Dec 11; 55(5):339-44. PubMed ID: 26028197
    [Abstract] [Full Text] [Related]

  • 17. [Guillain-Barré syndrome in CMV infection. Infectious and neurologic improvement with ganciclovir].
    Lindsten H, Binzer M, Boman J, Juto P.
    Lakartidningen; 1994 Mar 23; 91(12):1227-8. PubMed ID: 8189856
    [No Abstract] [Full Text] [Related]

  • 18. N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome.
    Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A, Kanazawa I.
    Ann Neurol; 1994 May 23; 35(5):570-6. PubMed ID: 8179303
    [Abstract] [Full Text] [Related]

  • 19. Guillain-Barre syndrome: first description of a snake envenomation aetiology.
    Neil J, Choumet V, Le Coupanec A, d'Alayer J, Demeret S, Musset L.
    J Neuroimmunol; 2012 Jan 18; 242(1-2):72-7. PubMed ID: 22172144
    [Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of cytomegalovirus infection and disease after lung or heart-lung transplantation with a delayed ganciclovir regimen.
    Thomas LD, Milstone AP, Miller GG, Loyd JE, Stephen Dummer J.
    Clin Transplant; 2009 Jan 18; 23(4):476-83. PubMed ID: 19453645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.